­

About Admin

Pharmaceutical analyst who loves blogging about health and medical issues. Has written more than 150 articles and a book on attention deficit disorder. Correctly predicted delayed approval of Bydureon, approval of Provenge by FDA, and the non-approval of Acthar on June 11.

Cetylev- A Promising New Alternative To An Old Classic

Cetylev is the new effervescent oral medication recently approved by the FDA for the treatment of acute liver toxicity, following over dosage of the popular drug Acetaminophen (better known as Tylenol). The drug contained in Cetylev; acetylcysteine, is not new by any means. In fact, it was approved since the 1960’s for use, albeit as [...]

Can Arthritis Patients Still Take COX-2 Inhibitors?

Millions of people suffer from arthritis and a host of arthritic and rheumatic conditions, which cause a great a deal of pain apart from loss of mobility. While NSAIDs (non-steroid anti-inflammatory drugs) are usually the first line of treatment, COX-2 inhibitors found favor as they had fewer side effects. Conventional painkillers like ibuprofen, paracetamol, aspirin [...]

Everyday Technology Has a Huge Role to Play in Drug Delivery Systems and Health Monitoring

These are exciting times when there are new drug delivery system either already here or slated to arrive shortly, targeted drugs for diseases and constant and easy health monitoring now available. Research and development is constantly on finding new drugs as also ways so that patients can have them painlessly and so that they reach [...]

Generic Drugs vs Brand Name Drugs – Are You Willing to Pay the Price?

Almost everyone knows that generic drugs are cheaper than brand name drugs – and the difference in price can be as much as 80 percent. Whether the money comes from your pocket (after all, a large percentage of the population has no health insurance) or you pay for a part of it as co-pay or [...]

Novartis’ Serelaxin Gets Breakthrough Therapy Status for Acute Heart Failure

The Food and Drug Administration (FDA) has just granted Serelaxin made by Novartis breakthrough designation for acute heart failure. This experimental drug, also called RLX030, has shown promising results in treating symptoms of acute heart failure (AHF) including shortness of breath, congestion and the worsening of heart failure and increasing their life-span as well. Typically [...]

Ibrutinib Under Research as a Breakthrough Oral Drug to Treat Leukamia

Leukemia or blood cancer is of different types. Conventional treatment including chemotherapy, radiotherapy and intracethal chemotherapy wherein the drugs are directly injected into the spinal canal has mixed results, with some people responding and some even going into remission, while in some the disease progresses. Stem cell transplants are sometimes given to patients from donors [...]

What Should You Do If You Are at Risk of Breast Cancer or Have Been Diagnosed With Breast Cancer?

Thanks to Angelina Jolie, breast cancer awareness in on the increase since news of her preventive mastectomies made headlines in mainstream press and media. Because her mother died of ovarian cancer, she decided to have herself genetically tested and learnt that she was at 65 percent risk of developing breast cancer and 50 percent risk [...]

Stroke Buster Drugs Make News

Stroke buster drugs called tissue plasminogen activators, were first approved by the FDA as far back as 1996. Long term studies on the use and effects of these drugs have shown that while the stroke busting drugs improve the quality of life, they don’t have a marked effect on survival rates. When a stroke is [...]

Xofigo for Prostate Cancer

The Food and Drug Administration has very recently approved a new pharmaceutical, Xofigo, for the treatment of late stage prostate cancer. The drug is a new hope for the treatment of a kind of cancer that affects more than 50% of men over 55 and over 90% of men over 75 years of age. It [...]

Novel Coronavirus Outbreak in the Mideast

There are periods when certain kinds of outbreaks or infectious diseases gain popularity in the media, even though mankind has never really known a time in the absence of such disease. Several years ago, SARS made a big impression in Europe and the Americas; more recently the various forms of avian and swine flu struck [...]